The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003071:Cognition / Q000187:drug effects; D018849:Controlled Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D004361:Drug Tolerance; D006801:Humans; D066298:In Vitro Techniques; D009025:Morpholines / Q000627:therapeutic use*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D000077593:Reboxetine; D011941:Receptors, Adrenergic / Q000378:metabolism; D012701:Serotonin / Q000494:pharmacology; D013995:Time
D018759:Adrenergic Uptake Inhibitors; D000928:Antidepressive Agents; D009025:Morpholines; D011941:Receptors, Adrenergic; D012701:Serotonin; D000077593:Reboxetine; D009638:Norepinephrine